Preclinical Efficacy of Dual mTORC1/2 Inhibitor AZD8055 in Renal Cell Carcinoma Harboring a TFE3 Gene Fusion
BMC Cancer - United Kingdom
doi 10.1186/s12885-019-6096-0
Full Text
Open PDFAbstract
Available in full text
Date
September 13, 2019
Authors
Publisher
Springer Science and Business Media LLC